Critical Care Outcomes in the Hematologic Transplant Recipient

被引：9

作者：

McArdle, John R. ^{[1
]}

机构：

[1] Yale Univ, Sch Med, Dept Med, Sect Pulm & Crit Care Med, New Haven, CT 06073 USA

来源：

CLINICS IN CHEST MEDICINE | 2009年 / 30卷 / 01期

关键词：

Bone marrow transplantation; Stem cell transplantation; Critical illness; Respiratory failure; Multiorgan system failure; Mechanical ventilation; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; CHILDREN REQUIRING ADMISSION; ONCOLOGICAL PEDIATRIC RISK; INVASIVE FUNGAL-INFECTIONS; INTENSIVE-CARE; ANTIFUNGAL PROPHYLAXIS; NEUTROPENIC PATIENTS; RESPIRATORY-FAILURE; CYTOMEGALOVIRUS DISEASE;

D O I：

10.1016/j.ccm.2008.10.002

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Critical illness is a dreaded complication in recipients of hematologic stem cell transplantation, with poor survival described in a number of early series. The perception of futility may impact the approach to therapy. Over the last 20 years, there have been significant advances in the application of intensive care, as well as changes in the management of patients before, during, and after transplantation. These advances and changes may have an impact on this traditionally poor survival. This article discusses the outcomes of critical illness in bone marrow and stem cell transplant recipients, and gives possible reasons for the apparent improvement in outcomes seen in more recent series.

引用

页码：155 / +

页数：15

共 60 条

[11] Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant
Cheuk, DKL
Ha, SY
Lee, SL
Chan, GCF
Tsoi, NS
Lau, YL
[J]. HEMATOLOGICAL ONCOLOGY, 2004, 22 (01) : 1 - 9
[12] Defibrotide in the treatment of children with veno-occlusive disease (VOD):: a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention
Corbacioglu, S
Greil, J
Peters, C
Wulffraat, N
Laws, HJ
Dilloo, D
Strahm, B
Gross-Wieltsch, U
Sykora, KW
Ridolfi-Lüthy, A
Basu, O
Gruhn, B
Güngör, T
Mihatsch, W
Schulz, A
[J]. BONE MARROW TRANSPLANTATION, 2004, 33 (02) : 189 - 195
[13] LONG-TERM SURVIVAL FROM RESPIRATORY-FAILURE AFTER MARROW TRANSPLANTATION FOR MALIGNANCY
CRAWFORD, SW
PETERSEN, FB
[J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (03): : 510 - 514
[14] *CTR INT BLOOD MAR, 2007, CURR US OUTC HEM STE
[15] EFFICACY OF INTENSIVE-CARE FOR BONE-MARROW TRANSPLANT PATIENTS WITH RESPIRATORY-FAILURE
DENARDO, SJ
OYE, RK
BELLAMY, PE
[J]. CRITICAL CARE MEDICINE, 1989, 17 (01) : 4 - 6
[16] DIAZ DH, 1999, BONE MARROW TRANSPL, V24, P163
[17] Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: Impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease
Erard, Veronique
Wald, Anna
Corey, Lawrence
Leisenring, Wendy M.
Boeckh, Michael
[J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (02) : 266 - 270
[18] Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies:: Evidence from a meta-analysis of 3,597 patients
Glasmacher, A
Prentice, A
Gorschlüter, M
Engelhart, S
Hahn, C
Djulbegovic, B
Schmidt-Wolf, IGH
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) : 4615 - 4626
[19] Risk score for pediatric intensive care unit admission in children undergoing hematopoietic stem cell transplantation and analysis of predictive factors for survival
González-Vicent, M
Marín, C
Madero, L
Sevilla, J
Diaz, MA
[J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2005, 27 (10) : 526 - 531
[20] Hagen Scott A, 2003, Pediatr Crit Care Med, V4, P206, DOI 10.1097/01.PCC.0000043293.83440.79

← 1 2 3 4 5 6 →